Dr. Joerg Traub (CEO)
Dr. Joerg Traub is one of the co-founders and managing director of SurgicEye GmbH. As a CEO he is responsible for General Management, Team Development, Business Development, Production, Marketing and Sales. During his studies of Computer Sciences at Technische Universität München (TUM), Dr. Traub worked for several high-tech companies in Germany, the USA and Singapore including BMW, Siemens and multiple internet start-up companies. In 2005 he received the Werner von Siemens Excellence Award for his exceptional thesis in the field of novel visualization concepts for minimally invasive surgery, in 2008 he received the Ph.D. in medical imaging and navigation with highest distinction.
Dr. Traub coordinated the Image Guided Surgery Group at the Department "Computer Aided Medical Procedures" at TUM where he prepared several industrial and clinical cooperation activities. He is author / co-author of over 40 international papers and eight patent applications. Under his supervision, several new image guided surgery systems were designed, developed and evaluated.
Alvaro Sanchez – Director R&D
Mr. Sanchez is responsible for SurgicEye's R&D projects as well as for the software development cycle.
He studied engineering physics with a focus on electronics. After working for a couple of years in business oriented positions he pursued a master's degree at KTH-Karolinska Institutet (Stockholm, Sweden) where he got a profound education in medical imaging and image processing. He later wrote his master's thesis at INRIA (Valbonne, France).
At SurgicEye he is a lead developer, R&D engineer and release manager. Additionally, he coordinates and participates in different engineering and research collaborations with business partners and research institutes.
Mr. Sanchez has exceptional experience in design and development of medical imaging algorithms and image guided surgery systems, project management, software development as well as extraordinary creativity and communication skills.
Matthias Keicher – Director Business development
Mr. Keicher is responsible for SurgicEye’s product management, marketing and sales as well as business development.
He studied Mechanical Engineering with a focus on medical technology at the Technical University of Munich (TUM). He got a profound education in the development of medical devices, medical imaging as well as biocompatible materials. In addition to his engineering skills he acquired expertise in product development, innovation management, marketing and the development of business models. Starting with an engineering position at SurgicEye he has since worked for two years as a product manager. He gained practical experience in sales, clinical applications, marketing as well as product development and R&D. His activities involved the development of clinical applications, market analysis and product definition. Moreover, he has been active in the commercial space with clinical partners, in addition to standard sales procedures also supporting clinical studies and installations.
Mr. Keicher has exceptional experience in the commercial space of medical products and a profound knowledge of applications in image guided surgery. He completed this with excellent project management expertise as well as extraordinary creativity and communication skills.
Michael Witt – Director of Operations
Michael Witt studied Biomedical Engineering at the Ilmenau University of Technology.
Mr. Witt is responsible for the quality and service at SurgicEye including the coordincation of after sales, general IT, production and regulatory affairs.
Prior to his assignments with SurgicEye he was a consultant for companies in trading and mechanical engineering as well as IT companies. He supported them defining and implementing their processes and starting new product lines, including the financing of these projects through grant funding.
As co-founder of several projects Michael Witt gained a lot of experience on bringing visions to reality. His main focus was on implementing necessary processes as easy as possible, legal topics as well as defining the base structures for successful teams.
Mr. Witt has exceptional skills communication and solution oriented thinking. He completes his skills with profound knowledge in medical system engineering, medical applications and service, providing always a reliable solution to challenging assignments.
SurgicEye's Advisory Board
Dr. Joerg Stroebel, Chairman of the Advisory Board
Dr. Jörg Ströbel is a management professional with extensive experience in medical equipment business combining scientific and engineering skills with marketing and sales. He has been working in various executive positions in health care and life science for more than 20 years. Since 5 years he acts as founder and Managing Partner of Nuremberg-based Efforma Concepts GmbH & Co. KG, a group of entrepreneurs in healthcare promoting and supporting innovative projects in life sciences and IT. He was Managing Partner of Ziehm Imaging GmbH and acted as business unit manager Bradyarrhythmia at Biotronik GmbH & Co. KG.
Dr. Stroebel is board member of the Sanoris-Foundation, Alumni of Young Leaders Forum BMW-Stiftung Herbert Quandt, as well as director "Medical Engineering" of the Koch-Metschnikow-Forum.
Dr. Stroebel studied Physics and completed his PhD at University of Erlangen-Nürnberg. He was a postdoctoral research fellow at IBM Research Lab in Rüschlikon, Switzerland.
Prof. Dr. Michael Friebe, Deputy Chairman of the Advisory Board
Prof. Dr. Friebe is Managing Director of m2f investment, a venture capital company for start-ups in the life sciences sector, as well as id+tm, a consulting company that specializes in medical technology. For almost 20 years in his capacity as founder and investor, he has started numerous companies in the field of medical imaging. In addition to his engagement at Surgiceye, Prof. Dr. Friebe is an Advisory Board Member of Curefab GmbH in Munich, a board member of Eckert&Ziegler BEBIG, as well as a lecturer at the Technical University Munich. He has an undergraduate degree in electrical engineering, a medical physics PhD (intra-operative applications for magnetic resonance imaging), a Management degree from a US university, and authored more than 40 medical imaging patent applications.
Dr. Adriaan Hart de Ruijter, Advisory Board Member
Dr Adriaan Hart de Ruijter is entrepreneur and investor in the life science industry, with a special interest in the clinical development, marketing and early adoption of technological innovation. He founded MSOURCE, a clinical research company for the pharmaceutical and medical device industry in 1994. MSOURCE completed numerous international clinical trials for medical device companies, leading to CE approval and IDE. After selling the company to TÜV SÜD in 2008, he focuses on venture capital, finance and advisory. Dr. Hart de Ruijter is a member of the Belgian College of Pharmaceutical Physicians and holds a medical degree of Leiden University and an MBA of the Rotterdam School of Management in the Netherlands.
Christian "Fred" Hieronimi, Advisory Board Member
Christian Hieronimi has founded "Medical Intelligence GmbH" in 1995 during studying economics at the University of Augsburg. The company concentrated on Medical Robotics and Patient Motion Management. It was VC funded by Startkapitalfonds Augsburg, Bayern Kapital, KfW and BayBG. Medical Intelligence sold in 2005 to Elekta, a 3500 employees strong corporation registered at the Stockholm Stock Exchange. After 6 years working in GVP positions at Elekta, Christian Hieronimi is now back in the entrepreneurial world, concentrating on systems for patient safety and quality assurance of complex processes in medicine. He is also shareholder of a number of start-up businesses.
Otto Hopfner, Advisory Board Member
Otto Hopfner graduated at the department of economics at Munich University (LMU). He then gained professional experience at an established bank in the Munich area. Afterwards he started to work for a partly state organized institution, which is specialized on loans and equity for small and medium-sized Bavarian companies. These companies are frequently at their start-up stage and represent a wide range of technological research and innovation. Besides, he has been appointed member of various advisory boards of the respective companies, whose economic progress and development he enjoys accompanying with as much expertise as possible.